 | • レポートコード：D0GIR-02585 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アルツハイマー病治療・診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。アルツハイマー病治療・診断の種類別市場規模（腰椎穿刺検査、コンピュータ断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波検査（EEG）、陽電子放射断層撮影（PET）スキャン、その他）、用途別市場規模（市販医薬品、パイプライン医薬品）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、H. Lundbeck、Forest Laboratories、Eisai、Johnson & Johnson.、Novartis、AC Immune、TauRx Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・アルツハイマー病治療・診断の北米市場（アメリカ、カナダ、メキシコ） ・アルツハイマー病治療・診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アルツハイマー病治療・診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アルツハイマー病治療・診断の南米市場（ブラジル、アルゼンチン） ・アルツハイマー病治療・診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腰椎穿刺検査、コンピュータ断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波検査（EEG）、陽電子放射断層撮影（PET）スキャン、その他 ・用途別分析：市販医薬品、パイプライン医薬品 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Alzheimer’s Disease Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 7829.6 million by 2025, from USD 6787.4 million in 2019.
The Alzheimer’s Disease Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alzheimer’s Disease Therapeutics and Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alzheimer’s Disease Therapeutics and Diagnostics market has been segmented into:
Lumbar puncture test
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)
Electroencephalography (EEG)
Positron emission tomography (PET) scan
Others
By Application, Alzheimer’s Disease Therapeutics and Diagnostics has been segmented into:
Marketed Drugs
Pipeline Drugs
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alzheimer’s Disease Therapeutics and Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Alzheimer’s Disease Therapeutics and Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alzheimer’s Disease Therapeutics and Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Alzheimer’s Disease Therapeutics and Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Alzheimer’s Disease Therapeutics and Diagnostics Market Share Analysis
Alzheimer’s Disease Therapeutics and Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alzheimer’s Disease Therapeutics and Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alzheimer’s Disease Therapeutics and Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Alzheimer’s Disease Therapeutics and Diagnostics are:
Pfizer
H. Lundbeck
Forest Laboratories
Eisai
Johnson & Johnson.
Novartis
AC Immune
TauRx Therapeutics
Table of Contents
1 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Therapeutics and Diagnostics
1.2 Classification of Alzheimer’s Disease Therapeutics and Diagnostics by Type
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type in 2019
1.2.3 Lumbar puncture test
1.2.4 Computed tomography (CT) scan
1.2.5 Magnetic resonance imaging (MRI)
1.2.6 Electroencephalography (EEG)
1.2.7 Positron emission tomography (PET) scan
1.2.8 Others
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Application
1.3.1 Overview: Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Marketed Drugs
1.3.3 Pipeline Drugs
1.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Regions
1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Alzheimer’s Disease Therapeutics and Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 H. Lundbeck
2.2.1 H. Lundbeck Details
2.2.2 H. Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 H. Lundbeck SWOT Analysis
2.2.4 H. Lundbeck Product and Services
2.2.5 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Forest Laboratories
2.3.1 Forest Laboratories Details
2.3.2 Forest Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Forest Laboratories SWOT Analysis
2.3.4 Forest Laboratories Product and Services
2.3.5 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eisai SWOT Analysis
2.4.4 Eisai Product and Services
2.4.5 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson.
2.5.1 Johnson & Johnson. Details
2.5.2 Johnson & Johnson. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson. SWOT Analysis
2.5.4 Johnson & Johnson. Product and Services
2.5.5 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 AC Immune
2.7.1 AC Immune Details
2.7.2 AC Immune Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AC Immune SWOT Analysis
2.7.4 AC Immune Product and Services
2.7.5 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 TauRx Therapeutics
2.8.1 TauRx Therapeutics Details
2.8.2 TauRx Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 TauRx Therapeutics SWOT Analysis
2.8.4 TauRx Therapeutics Product and Services
2.8.5 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Alzheimer’s Disease Therapeutics and Diagnostics Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Therapeutics and Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Regions
4.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries
5.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
5.2 USA Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries
6.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries
7.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
7.2 China Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries
8.1 South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Alzheimer’s Disease Therapeutics and Diagnostics by Countries
9.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Type (2019-2024)
10.3 Lumbar puncture test Revenue Growth Rate (2015-2025)
10.4 Computed tomography (CT) scan Revenue Growth Rate (2015-2025)
10.5 Magnetic resonance imaging (MRI) Revenue Growth Rate (2015-2025)
10.6 Electroencephalography (EEG) Revenue Growth Rate (2015-2025)
10.7 Positron emission tomography (PET) scan Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment by Application
11.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Application (2019-2024)
11.3 Marketed Drugs Revenue Growth (2015-2020)
11.4 Pipeline Drugs Revenue Growth (2015-2020)
12 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Forecast (2021-2025)
12.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Forecast (2021-2025)
12.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alzheimer’s Disease Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 7. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 10. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. H. Lundbeck Corporate Information, Location and Competitors
Table 12. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 13. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. H. Lundbeck SWOT Analysis
Table 15. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 16. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Forest Laboratories Corporate Information, Location and Competitors
Table 18. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 19. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Forest Laboratories SWOT Analysis
Table 21. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 22. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Eisai Corporate Information, Location and Competitors
Table 24. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 25. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Eisai SWOT Analysis
Table 27. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 28. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson & Johnson. Corporate Information, Location and Competitors
Table 30. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 31. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Johnson & Johnson. SWOT Analysis
Table 33. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 34. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 37. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 40. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AC Immune Corporate Information, Location and Competitors
Table 42. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 43. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. AC Immune SWOT Analysis
Table 45. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 46. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. TauRx Therapeutics Corporate Information, Location and Competitors
Table 48. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Major Business
Table 49. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. TauRx Therapeutics SWOT Analysis
Table 51. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product and Solutions
Table 52. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Players (2015-2020)
Table 55. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Regions (2015-2020)
Table 57. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
Table 58. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries (2015-2020)
Table 62. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 65. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Table 67. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Forecast by Type (2021-2025)
Table 68. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Application (2015-2020)
Table 69. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Application (2015-2020)
Table 70. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Forecast by Application (2021-2025)
Table 71. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Alzheimer’s Disease Therapeutics and Diagnostics Picture
Figure 2. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type in 2019
Figure 3. Lumbar puncture test Picture
Figure 4. Computed tomography (CT) scan Picture
Figure 5. Magnetic resonance imaging (MRI) Picture
Figure 6. Electroencephalography (EEG) Picture
Figure 7. Positron emission tomography (PET) scan Picture
Figure 8. Others Picture
Figure 9. Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application in 2019
Figure 10. Marketed Drugs Picture
Figure 11. Pipeline Drugs Picture
Figure 12. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Regions in 2018
Figure 26. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries in 2019
Figure 33. USA Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries in 2019
Figure 38. Germany Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. UK Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. France Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries in 2019
Figure 45. China Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. India Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries in 2019
Figure 52. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Type (2015-2020)
Figure 61. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Type in 2019
Figure 62. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Type (2021-2025)
Figure 63. Global Lumbar puncture test Revenue Growth Rate (2015-2020)
Figure 64. Global Computed tomography (CT) scan Revenue Growth Rate (2015-2020)
Figure 65. Global Magnetic resonance imaging (MRI) Revenue Growth Rate (2015-2020)
Figure 66. Global Electroencephalography (EEG) Revenue Growth Rate (2015-2020)
Figure 67. Global Positron emission tomography (PET) scan Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Application (2015-2020)
Figure 70. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Application in 2019
Figure 71. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Application (2021-2025)
Figure 72. Global Marketed Drugs Revenue Growth Rate (2015-2020)
Figure 73. Global Pipeline Drugs Revenue Growth Rate (2015-2020)
Figure 74. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
胃食道逆流症（GERD）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4989.6 million by 2025, from USD 4870.2 milli…- 肝疾患診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Liver Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 膀胱癌治療・診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- アルツハイマーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alzheimer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer market report provides a …
- 感染症検査における分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…